Nasr R.; El-Sabban M.E.; Karam J.-A.; Dbaibo G.; Kfoury Y.; Arnulf B.; Lepelletier Y.; Bex F.; De The H.; Hermine O.; Bazarbachi A.
(LONDONMACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, 2005)
HTLV-I associated adult T-cell leukemia (ATL) and HTLV-I-negative peripheral T-cell lymphomas are associated with poor prognosis. Using pharmacological concentrations of the proteasome inhibitor PS-341, we demonstrate ...